Is there a recognised cardio-oncology group or society in your country?
The initiative to develop a national cardio-oncology programme was launched three years ago, reflecting Serbia's commitment to advancing multidisciplinary cardiovascular care for patients undergoing oncological treatment. In the previous year, the formal establishment of the Cardio-Oncology Working Group was commenced, intended to function as a structured professional body within the Cardiology Society of Serbia. Due to the ongoing crisis in the country, the official confirmation and inaugural meeting of the Executive Board of the Cardiology Society of Serbia have been delayed. The Working Group remains prepared for the next steps and is awaiting the Board's approval to proceed. Upon formal endorsement, the Working Group will be formally presented, and coordinated collaborative activities with the Society of Oncology will be initiated, with the objective of strengthening inter-specialty cooperation and improving the quality of cardio-oncological care at the national level.
Clinical Practice
Formally established, dedicated cardio-oncology clinics are not yet in place. However, multidisciplinary teams – including oncologists, cardiologists, and radiologists – are actively engaged in patient evaluation and management. Within the University Clinical Centres, the steps recommended by international practice guidelines are implemented consistently before, during, and after cancer treatment, ensuring standardised cardiovascular assessment and follow-up throughout the entire oncological care pathway.
Education
Educational activities in the field have been supported through strong professional synergy and participation in major national and regional events, including the National Congress of Cardiologists of Serbia, AMEC, the Oncology Section of the Serbian Medical Society, the Cardionaissus Meeting, and SINERGY, as well as a series of multidisciplinary workshops.
Research
The Serbian cardio-oncology community is actively engaged in several research and educational initiatives. These include the development of a Multicenter Registry of cancer patients hospitalised in Cardiology Clinics and Departments, as well as participation in the Regional Registry of Patients with Pulmonary Embolism (REPER), with a dedicated sub-analysis focusing on cancer-associated pulmonary thromboembolism. Contributions to the field are also made through the publication of scientific articles and the organization of multidisciplinary meetings, including accredited lectures that emphasize the management of cancer patients within cardiology practice.
